Why It Matters
This analyst upgrade signals a positive outlook for Biogen's future performance, which could influence investor sentiment and the company's stock valuation.
Key Intelligence
- ■TD Cowen has updated its financial model for Biogen.
- ■The firm has increased its stock price target for Biogen to $250.